Atlas Trials

Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders

Clinical trial NCT02156115 · TERMINATED

Trial details

NCT number
NCT02156115
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
TERMINATED
Study type
OBSERVATIONAL
LymphangiomatosisLymphedemaLymphangiectasiaPulmonary Lymphangiectasia
Start date
2015-03-23
Primary completion
2024-04-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.